These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24339293)

  • 1. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia.
    Lee HJ; Lee YJ; Choi CW; Lee JA; Kim EK; Kim HS; Kim BI; Choi JH
    Yonsei Med J; 2014 Jan; 55(1):99-106. PubMed ID: 24339293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone.
    Dasgupta C; Sakurai R; Wang Y; Guo P; Ambalavanan N; Torday JS; Rehan VK
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L1031-41. PubMed ID: 19304912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo.
    Rehan VK; Wang Y; Patel S; Santos J; Torday JS
    Pediatr Pulmonol; 2006 Jun; 41(6):558-69. PubMed ID: 16617452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury.
    Rehan VK; Sakurai R; Corral J; Krebs M; Ibe B; Ihida-Stansbury K; Torday JS
    Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L672-80. PubMed ID: 20729387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone.
    Nicola T; Ambalavanan N; Zhang W; James ML; Rehan V; Halloran B; Olave N; Bulger A; Oparil S; Chen YF
    Am J Physiol Lung Cell Mol Physiol; 2011 Jul; 301(1):L125-34. PubMed ID: 21531777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR-γ agonist rosiglitazone reverses perinatal nicotine exposure-induced asthma in rat offspring.
    Liu J; Sakurai R; Rehan VK
    Am J Physiol Lung Cell Mol Physiol; 2015 Apr; 308(8):L788-96. PubMed ID: 25659902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental Bronchopulmonary Dysplasia.
    Hirsch K; Taglauer E; Seedorf G; Callahan C; Mandell E; White CW; Kourembanas S; Abman SH
    Am J Respir Crit Care Med; 2020 Oct; 202(8):1146-1158. PubMed ID: 32551816
    [No Abstract]   [Full Text] [Related]  

  • 8. rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia.
    Seedorf G; Kim C; Wallace B; Mandell EW; Nowlin T; Shepherd D; Abman SH
    Am J Respir Crit Care Med; 2020 May; 201(9):1120-1134. PubMed ID: 32101461
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism.
    Qu S; Shan L; Chen X; Zhang Z; Wu Y; Chen Y; Zhuo F; Wang Y; Dong H
    BMC Pulm Med; 2023 Jun; 23(1):209. PubMed ID: 37322452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-tracheal administration of a naked plasmid expressing stromal derived factor-1 improves lung structure in rodents with experimental bronchopulmonary dysplasia.
    Guerra K; Bryan C; Dapaah-Siakwan F; Sammour I; Drummond S; Zambrano R; Chen P; Huang J; Sharma M; Shrager S; Benny M; Wu S; Young KC
    Respir Res; 2019 Nov; 20(1):255. PubMed ID: 31718614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of increased pulmonary interleukin-6 with the priming effect of intra-amniotic lipopolysaccharide on hyperoxic lung injury in a rat model of bronchopulmonary dysplasia.
    Kim DH; Choi CW; Kim EK; Kim HS; Kim BI; Choi JH; Lee MJ; Yang EG
    Neonatology; 2010 Jun; 98(1):23-32. PubMed ID: 19955834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deferoxamine Improves Alveolar and Pulmonary Vascular Development by Upregulating Hypoxia-inducible Factor-1α in a Rat Model of Bronchopulmonary Dysplasia.
    Choi CW; Lee J; Lee HJ; Park HS; Chun YS; Kim BI
    J Korean Med Sci; 2015 Sep; 30(9):1295-301. PubMed ID: 26339170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia.
    Tang JR; Karumanchi SA; Seedorf G; Markham N; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(1):L36-46. PubMed ID: 22003089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model.
    Wang Y; Santos J; Sakurai R; Shin E; Cerny L; Torday JS; Rehan VK
    Pediatr Res; 2009 Feb; 65(2):150-5. PubMed ID: 19262292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D; Zeng BX; Zhang SH; Yao SL
    Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of intra-amniotic endotoxin priming plus hyperoxic exposure on the expression of vascular endothelial growth factor and its receptors in lungs of preterm newborn rats].
    Wang W; Wei W; Ning Q; Luo XP
    Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):533-8. PubMed ID: 17953812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Combination of the Aerosolized PPAR-γ Agonist Pioglitazone and a Synthetic Surfactant Protein B Peptide Mimic Prevents Hyperoxia-Induced Neonatal Lung Injury in Rats.
    Sakurai R; Lee C; Shen H; Waring AJ; Walther FJ; Rehan VK
    Neonatology; 2018; 113(4):296-304. PubMed ID: 29428947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
    Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
    PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.
    Yang SJ; Choi JM; Chae SW; Kim WJ; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Kim SW; Park CY
    PLoS One; 2011 Feb; 6(2):e17057. PubMed ID: 21373642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR-gamma agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis.
    Hassumi MY; Silva-Filho VJ; Campos-Júnior JC; Vieira SM; Cunha FQ; Alves PM; Alves JB; Kawai T; Gonçalves RB; Napimoga MH
    Int Immunopharmacol; 2009 Sep; 9(10):1150-8. PubMed ID: 19508902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.